Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas

Citations Over TimeTop 1% of 2009 papers

Abstract

We report genetic aberrations that activate the ERK/MAP kinase pathway in 100% of posterior fossa pilocytic astrocytomas, with a high frequency of gene fusions between KIAA1549 and BRAF among these tumours. These fusions were identified from analysis of focal copy number gains at 7q34, detected using Affymetrix 250K and 6.0 SNP arrays. PCR and sequencing confirmed the presence of five KIAA1549-BRAF fusion variants, along with a single fusion between SRGAP3 and RAF1. The resulting fusion genes lack the auto-inhibitory domains of BRAF and RAF1, which are replaced in-frame by the beginning of KIAA1549 and SRGAP3, respectively, conferring constitutive kinase activity. An activating mutation of KRAS was identified in the single pilocytic astrocytoma without a BRAF or RAF1 fusion. Further fusions and activating mutations in BRAF were identified in 28% of grade II astrocytomas, highlighting the importance of the ERK/MAP kinase pathway in the development of paediatric low-grade gliomas.

Related Papers

• → Pediatric low-grade gliomas and the need for new options for therapy: why and how?(2009)56 cited
• → Clinicopathological features and global genomic copy number alterations of pilomyxoid astrocytoma in the hypothalamus/optic pathway: comparative analysis with pilocytic astrocytoma using array-based comparative genomic hybridization(2008)43 cited
• → Pilomyxoid astrocytoma in an adult woman(2015)2 cited
• → Low-Grade Astrocytoma Variants(2000)1 cited
• → Atypical pilocytic astrocytoma of adult spinal cord: A case report(2018)